Picture: 123RF/RA2
Picture: 123RF/RA2

It’s been an important week in the continued battle against Covid-19, with the Johnson & Johnson (J&J) vaccine facing a hurdle that appears to be nothing more than a storm in a teacup. On Friday, the second phase of the country’s vaccination strategy kicked off with electronic registration for over 60s.

It’s unclear, at this stage, whether the government’s decision to pause the J&J vaccine rollout will have a material impact given that it hasn’t even started yet. This while China’s GDP jumped a record 18.3% in the first quarter from a year earlier, official data showed on Friday, slower than the 19% forecast by economists in a Reuters poll, and following 6.5% growth in the fourth quarter of 2020.

Michael Avery speaks to Warwick Lucas, chief investment officer at Galileo Asset Managers; Raymond Parsons, professor at the School of Business and Governance at North West University; and a special guest this week, Stavros Nicolaou, head of the health working group for Business for SA, to review the week that was.

Michael Avery takes a look at the performance of different sectors within the economy with his guest experts

Or listen to the full audio:

Subscribe for free episodes: iono.fm | Apple PodcastsSpotify | Pocket Casts | Player.fm

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.